Invicta Diagnostic (NSE:INVICTA) Beta: N/A (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INVICTA Invicta Diagnostic Ltd NSE:INVICTA
22 GF Score
Price ₹69.65
! 3 Warning Signs
View Full Analysis

What is Invicta Diagnostic Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-20), Invicta Diagnostic's Beta is Not available.

Invicta Diagnostic  (NSE:INVICTA) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Invicta Diagnostic Beta Related Terms

Invicta Diagnostic Beta Historical Data

* Premium members only.

The historical data trend for Invicta Diagnostic's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invicta Diagnostic Beta Chart

Invicta Diagnostic Annual Data
Trend Mar24 Mar25 Mar26
Beta
0.00 0.00 0.00

Invicta Diagnostic Semi-Annual Data
Mar24 Mar25 Sep25 Mar26
Beta 0.00 0.00 0.00 0.00
NSE:INVICTA
22GF Score
Invicta Diagnostic Ltd NSE:INVICTA
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Invicta Diagnostic Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Invicta Diagnostic Business Description

Address Western Express Highway, Office No. 1012, 10th Floor, Hubtown Viva CHS Ltd, Mogra Village, Near Shankarwadi, Jogeshwari East, Mumbai, MH, IND, 400 060
Invicta Diagnostic Ltd is engaged in the business of medical and diagnostic services and operates diagnostic centres providing medical testing and allied healthcare services in the Mumbai Metropolitan Region. The Company runs a diagnostic chain comprising seven diagnostic centres and one centralised laboratory across MMR in Maharashtra and operates under a hub and spoke model with a flagship hub in Thane, additional hub centres, spoke centres, and a centralised laboratory. Its service offerings include radiology and imaging, pathology and clinical laboratory tests, teleradiology, and services such as ultrasound, X Ray, CT scan, MRI scan, PET scan, and cardiac diagnostics, with patient convenience supported through home sample collection, house calls, and multiple report delivery options.
22GF Score

Get the complete analysis for NSE:INVICTA

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹69.65
Price